logo
Select company
Select metric
81.64%Cash to Assets Ratio
VS
Market
97
Sector
89
Industry
83
History
55
$ 2Close
$ 0.54 - $ 3.91 52-Week Range
Ticker Information

Ticker

PALI

Company Name

PALISADE BIO INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

PALISADE BIO INC - Cash to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

PALI - Cash to Assets Historical data
DateTotal AssetsCash and EquivalentsCash to Assets Ratio
6/30/2025$ 6.67M$ 5.44M81.64%
3/31/2025$ 8.19M$ 7.26M88.6%
12/31/2024$ 10.88M$ 9.85M90.51%
9/30/2024$ 9.34M$ 8.07M86.4%
6/30/2024$ 12.87M$ 11.38M88.41%
3/31/2024$ 12.65M$ 11.3M89.33%
12/31/2023$ 14.05M$ 12.46M88.66%
9/30/2023$ 17.07M$ 15.34M89.87%
6/30/2023$ 18.29M$ 16.43M89.83%
3/31/2023$ 15.26M$ 13.32M87.3%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Definition of Cash to Assets Ratio

[Calculation] The Cash to Assets Ratio expresses a company’s cash and cash equivalents [CashnEq] as a percentage of total [Assets].
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for PALISADE BIO INC is calculated as follows: CashnEq [ $ 12.65M ] / Assets [ $ 15.17M ]
(=) Cash to Assets [ 83.4% ]

PALI - Cash to Assets Ratio, Last 5 years

64.13%

Minimum

Jun 30, 2022

90.51%

Maximum

Dec 31, 2024

84.14%

Average

86.27%

Median

Cash to Assets Benchmark Analysis

The chart above depicts the distribution of Cash to Assets for companies in the Total Stock Market. The average Cash to Assets of the companies is 9.76% with a standard deviation of 9.51%.
The following table provides additional summary stats:
Cash to Assets in the Market:
filtered constituents3.94K
min0%
max40.71%
average9.76%
median6.41%
std9.51%